Crossmark

Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset

Crossref DOI link: https://doi.org/10.1007/s00210-018-1549-6

Published Online: 2018-08-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hamadjida, Adjia

Nuara, Stephen G.

Bédard, Dominique

Frouni, Imane

Kwan, Cynthia

Gourdon, Jim C.

Huot, Philippe
Funding

Funding for this research was provided by:

Weston Brain Institute

Parkinson Canada

Fonds de Recherche du Québec - Santé
License Information

Text and Data Mining valid from 2018-08-07
More Information

Article History

Received: 12 June 2018

Accepted: 25 July 2018

First Online: 7 August 2018

Compliance with ethical standards

: All experiments reported in this article were conducted in accordance with a protocol approved by McGill University and the Montreal Neurological Institute Animal Care Committees in accordance with the regulations defined by the Canadian Council on Animal Care.

: The authors declare that they have no conflicts of interest.